High-Dose CD20-Targeted Radioimmunotherapy-Based Autologous Transplantation Improves Outcomes for Persistent Mantle Cell Lymphoma

Autologous stem cell transplant (ASCT) can improve outcomes for mantle cell lymphoma (MCL) patients, yet relapses are frequent. We hypothesized that high-dose anti-CD20 radioimmunotherapy (RIT)-based conditioning could improve results in this setting. We thus assessed 162 consecutive patients with M...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Br J Haematol
Main Authors: Cassaday, Ryan D., Stevenson, Philip A., Gooley, Theodore A., Chauncey, Thomas R., Pagel, John M., Rajendran, Joseph, Till, Brian G., Philip, Mary, Orozco, Johnnie J., Bensinger, William I., Holmberg, Leona A., Shustov, Andrei R., Green, Damian J., Smith, Stephen D., Libby, Edward N., Maloney, David G., Press, Oliver W., Gopal, Ajay K.
Formato: Artigo
Idioma:Inglês
Publicado: 2015
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4715476/
https://ncbi.nlm.nih.gov/pubmed/26455717
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bjh.13773
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares